Scotia Capital’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Scotia Capital’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,512	Closed	-$379K	–	731
2020 Q1	$379K	Sell	10,512 -1	-0%	-$43	0.01%	470
2019 Q4	$480K	Sell	10,513 -495	-4%	-$19.6K	0.01%	522
2019 Q3	$392K	Sell	11,008 -17,919	-62%	-$666K	﹤0.01%	561
2019 Q2	$1.15M	Buy	28,927 +265	+0.9%	+$10.4K	0.01%	373
2019 Q1	$1.19M	Buy	+28,662	New	+$1.16M	0.02%	355

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Scotia Capital's XPH Position: Q2 2020 in Review

Scotia Capital sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2020, closing a stake of 10,512 shares — an estimated $379K sold.

Scotia Capital first reported a position in XPH in Q1 2019 and held it in 5 quarters. The position peaked at $1.19M in Q1 2019. 73 funds tracked by Wall St. Rank hold XPH as of Q2 2020.

Scotia Capital reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
Scotia Capital sold 10,512 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2020, an estimated $379K.
Scotia Capital first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2019 and held it in 5 quarters.
Scotia Capital's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.19M in Q1 2019.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2020.

Based on Scotia Capital's 13F filing for Q2 2020, filed 11 Aug 2020.